1st Quarter - Report

VENABLE LLP for GLOBAL ANTIBIOTIC RESEARCH & DEVELOPMENT PARTNERSHIP, NORTH AMERICA (GARDP NA)

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY 23 Labor, Health and Human Services, Education, and State and Foreign Operations appropriations regarding antibiotic research and development.

Foreign entity interest: Global Antibiotic Research and Development Partnership (GARDP), listed on the registration, has an interest in the issues disclosed above.

LobbyistCovered position, as disclosed
JODIE CURTIS —
LAURA A HANEN —

Contacted: HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Antibiotic research and development; S. 3799, PREVENT Pandemics Act.

Foreign entity interest: Global Antibiotic Research and Development Partnership (GARDP), listed on the registration, has an interest in the issues disclosed above.

LobbyistCovered position, as disclosed
JODIE CURTIS —
LAURA A HANEN —

Contacted: Office of Science & Technology Policy (OSTP)

Bills named: S. 3799 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.